Global Clinical Trial Biorepository & Archiving Solutions Market

Report ID : 1385 | Published : 2022-10-06 | Pages: | Format: PDF/EXCEL

The market size of the Global Clinical Trial Biorepository & Archiving Solutions market in the year 2021 is valued at 3.68 billion and is predicted to reach 7.92 billion by the year 2030 at an 9.22% CAGR during the forecast period.

There has been a massive increase in the demand for storage capacities at shallow temperatures due to the recent explosive growth of immunotherapy, stem cell therapy, and other regenerative medicine fields. By contracting with biorepositories, pharmaceutical businesses can lessen the inherent biohazard hazards and regulatory delays connected with the maintenance and management of significant amounts of liquid nitrogen. Due to translational research and individualized therapy availability, biobanking has been a crucial area to increase growth within these industries. Biobanks have significantly increased the number of samples gathered for biomarker and companion diagnostic studies. The rising interest in biomarkers is driving this development as a way to comprehend and pinpoint the molecular causes of disease.

However, the growth is largely attributed to the expanding fields of personalized, precision, and genomic medicine, as well as to an increase in R&D investments, the proliferation of low-cost computers, and a push to make data collection and reporting simpler by using software like LIMS for the management of laboratory samples. To free up resources for pharmaceutical development, an increasing number of organizations are outsourcing cold-chain and storage activities. It can be time-consuming and labor-intensive to stay on top of storage and transportation technology advances, international regulatory standards, and bio-storage trends.

Market Segmentation:

The Clinical Trial Biorepository & Archiving Solutions market is segmented on the service, product, and phase. Based on service, the market is segmented into Biorepository Services (Warehousing & Storage, Transportation, Sample Processing and Others) and Archiving Solution Services (Database Indexing and Management and Scanning & Destruction). Based on product, the Clinical Trial Biorepository & Archiving Solutions are segmented into Preclinical Products and Clinical Products (Human Tissue, Organs, Stem Cells and Other Biospecimens). Based on the Phase, the Clinical Trial Biorepository & Archiving Solutions are segmented into Phase I, Phase II, Phase III and Phase IV.

Based on service, the Biorepository Services segment is accounted as a significant contributor to the Clinical Trial Biorepository & Archiving Solutions market.

Based on service, the market is segmented into Biorepository Services (Warehousing & Storage, Transportation, Sample Processing and Others) and Archiving Solution Services (Database Indexing and Management and Scanning & Destruction). The biorepository service category dominated the market. Collection, processing, storage, and distribution of samples and other associated services are the key components of biorepository services. Strategic planning and implementation, supplies and reagents for high-quality collection, storage, and retrieval, physical space for operations and equipment, and IT infrastructure for sample monitoring and management are all necessary to form a high-quality biorepository.

The phase III segment witnessed growth at a rapid rate.

Researchers conducting phase III clinical studies contrast the novel therapy's safety and efficacy with the industry norm. Most phase III clinical trials have a sizeable patient population, usually several hundred. Furthermore, long-term and unexpected side effects are more likely to emerge due to the substantial participant pool and lengthy phase duration. Since phase III trials require the storage of a variety of samples and specimens for lengthy research, clinical trial biorepository and archiving solutions services are particularly crucial.

The North American Clinical Trial Biorepository & Archiving Solutions market holds a significant regional revenue share.

The North American Clinical Trial Biorepository & Archiving Solutions market is expected to register the highest market share in revenue in the near future. The increased frequency of clinical trials is one of the significant variables influencing the local market. Additionally, the industry's abundance of businesses creates additional opportunities for the need for clinical trial biorepository & archiving solutions to expand quickly. American pharmaceutical companies spend more money on R&D than most other industries. In addition, Asia Pacific is projected to grow in the global Clinical Trial Biorepository & Archiving Solutions market. The growing use of clinical trials Biorepository & Archiving Solutions, the presence of significant organizations and the availability of cutting-edge technology are driving the market forward. Among the key reasons driving this regional market are an increase in clinical trials, a large number of market participants, and the availability of current technology.

Competitive Landscape

The key players in the Clinical Trial Biorepository & Archiving Solutions market have shifted their focus toward product manufacturing and are initiating significant strategies such as mergers, acquisitions, and joint ventures of major and domestic players to enhance their product portfolio and strengthen their global market footprint. Some major key players in the Clinical Trial Biorepository Archiving Solutions market are Brooks Life Science, Patheon, Precision for Medicine, Inc., Medpace, LabCorp Drug Development, ATCC, Q2 Solutions, Labconnect, Charles River Laboratories and Cell&Co.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Clinical Trial Biorepository & Archiving Solutions Market Snapshot

Chapter 4. Global Clinical Trial Biorepository & Archiving Solutions Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Service Estimates & Trend Analysis

5.1. by Service & Market Share, 2019 & 2030

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Service:

5.2.1. Biorepository Services

5.2.1.1. Warehousing & Storage

5.2.1.2. Transportation

5.2.1.3. Sample Processing

5.2.1.4. Others

5.2.2. Archiving Solution Services

5.2.2.1. Database Indexing and Management

5.2.2.2. Scanning & Destruction

Chapter 6. Market Segmentation 2: by Product Estimates & Trend Analysis

6.1. by Product & Market Share, 2019 & 2030

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Product:

6.2.1. Preclinical Products

6.2.2. Clinical Products

6.2.3. Human Tissue

6.2.4. Organs

6.2.5. Stem Cells

6.2.6. Other Biospecimens

Chapter 7. Market Segmentation 3: by Phase Estimates & Trend Analysis

7.1. by Phase & Market Share, 2019 & 2030

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Phase:

7.2.1. Phase I

7.2.2. Phase II

7.2.3. Phase III

7.2.4. Phase IV

Chapter 8. Clinical Trial Biorepository & Archiving Solutions Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Clinical Trial Biorepository & Archiving Solutions Market Revenue (US$ Million) Estimates and Forecasts by Service, 2022-2030

8.1.2. North America Clinical Trial Biorepository & Archiving Solutions Market Revenue (US$ Million) Estimates and Forecasts by Product, 2022-2030

8.1.3. North America Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by Phase, 2022-2030

8.1.4. North America Clinical Trial Biorepository & Archiving Solutions Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.2. Europe

8.2.1. Europe Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by Service, 2022-2030

8.2.2. Europe Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by Product, 2022-2030

8.2.3. Europe Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by Phase, 2022-2030

8.2.4. Europe Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by country, 2022-2030

8.3. Asia Pacific

8.3.1. Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by Service, 2022-2030

8.3.2. Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by Product, 2022-2030

8.3.3. Asia-Pacific Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by Phase, 2022-2030

8.3.4. Asia Pacific Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by country, 2022-2030

8.4. Latin America

8.4.1. Latin America Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by Service, 2022-2030

8.4.2. Latin America Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by Product, 2022-2030

8.4.3. Latin America Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by Phase, 2022-2030

8.4.4. Latin America Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by country, 2022-2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by Service, 2022-2030

8.5.2. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by Product, 2022-2030

8.5.3. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by Phase, 2022-2030

8.5.4. Middle East & Africa Clinical Trial Biorepository & Archiving Solutions Market revenue (US$ Million) by country, 2022-2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Brooks Life Science

9.2.2. Patheon

9.2.3. Precision for Medicine, Inc.

9.2.4. Medpace

9.2.5. LabCorp Drug Development

9.2.6. ATCC

9.2.7. Q2 Solutions

9.2.8. Labconnect

9.2.9. Charles River Laboratories

9.2.10. Cell&Co

9.2.11. Other Prominent Players

By Service-

  • Biorepository Services
    • Warehousing & Storage
    • Transportation
    • Sample Processing
    • Others
  • Archiving Solution Services
    • Database Indexing and Management
    • Scanning & Destruction

By Product-

  • Preclinical Products
  • Clinical Products
    • Human Tissue
    • Organs
    • Stem Cells
    • Other Biospecimens

By Phase-

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa

Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients